It is generally accepted that the development of the immune system in children is sensitive to environmental agents. In particular, growing evidence indicates that the development of immunity to inhaled antigens can be influenced by coexposure to airborne irritants, which can influence the functions of bone marrow-derived cells. There is also indirect evidence from human epidemiologic studies (1) that exposure of school children to molds can exacerbate atopic symptoms.
This article describes a working model for the interaction between the environment and immune function in children and illustrates how exposure to molds could be a significant modifying factor.
Immunologic Features of the Natural History of Allergic Respiratory Disease

Aliergen-Specific Immunity in Adults
It is now generally accepted that active T-cell immunity against common inhalant allergens is universal among adults, and allergen responder phenotype is determined by the nature of the cytokines produced by allergen-specific T helper (Th) memory cells at each exposure (2, 3 In normal (nonatopic) children, these early Th2 responses are progressively converted to Thl via a process known as immune deviation (4,6), and Th memory patterns similar to those of adults are seen by approximately 5 years of age (9) . However, for reasons not yet fully understood, this immune deviation process frequently fails in children with atopic family history, leading instead to consolidation of allergen-specific Th2 immunity, and hence heightened risk for allergy (9) . This may be due in part to a transient maturational defect in ThI function in atopics (4,6). The best documented of these environmental factors is respiratory virus infection, which has been identified as a major trigger for asthma exacerbation in subjects with pre-existing atopy (11) , particularly in school children. Air pollution may also play a role, although the effects are probably relatively minor except in extreme circumstances (12) . Furthermore, microbial cell wall constituents such as endotoxin (13, 14) and molds (14) interfere with cells engaged in the inflammatory-immune process. Molds are well-known antigens and may also cause nonspecific inflammatory response. In their cell walls they contain (1-*3)-P-D-glucan with wellknown inflammatory and immunogenic properties (15, 16) .
(1 -*3)-4-D-glucan causes cell infiltration in lung tissue and a reduction of antibody formation to an inhaled antigen (17) . In a mouse model, the normal downregulation of the allergen-specific IgE response was abrogated by glucan exposure (18) . Other studies have demonstrated that exposure of inflammatory cells to (1-*3)-P-D-glucan can trigger secretion of mediator molecules known to influence immune responses (19) .
Depending on the dose and timing of the exposure, environmental agents could exert effects on at least two levels, as illustrated in Figure 1 .
Thl/Th2 Regulation during Th-cell Memory Development. The postnatal modulation of fetally primed Th-cell responses to allergens is regulated principally by antigen-presenting cells (APCs) in the airway mucosa such as macrophages and dendritic cells. These express surface receptors for ,B-glucan. The triggering of these receptors is likely to influence a variety of their functions associated with allergen uptake and processing (particularly cytokine secretion), all of which can modulate ensuing Th-cell responses. The influx and efflux of local APCs is also regulated by the intensity and frequency of exposure to local microbial stimuli (20) .
Expression ofAllergen-Specific Th2 Responses in the Airway Mucosa. The defining feature of atopic asthma is the presence of large numbers of activated Th cells in the airway mucosa. The activity of these cells is in turn regulated by inductive signals from local APCs and by their secreted (cytokine) products. As indicated above, co-exposure to ,B-glucan has the potential to modulate the functions of these APCs.
Recent studies from several laboratories indicate that secreted products from alveolar macrophages play a key role in regulating the tonus of immunoinflammatory responses in the airways (21, 22 
